drugset / Trial / NCT06195137
Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study was to evaluate the efficacy of caffeine and alpha-lipoic acid in the treatment of burning mouth syndrome by symptom assessment with visual analogue scale.
Timeline
- Start
- 2021-12-13
- Primary completion
- 2023-06-15
- Completion
- 2023-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | alpha-lipoic acid | Small molecule | 200 mg | — |